Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

MSCV-IRES-Tomato MEF2C S222A Citations (1)

Originally described in: MEF2C Phosphorylation Is Required for Chemotherapy Resistance in Acute Myeloid Leukemia.
Brown FC, Still E, Koche RP, Yim CY, Takao S, Cifani P, Reed C, Gunasekera S, Ficarro SB, Romanienko P, Mark W, McCarthy C, de Stanchina E, Gonen M, Seshan V, Bhola P, O'Donnell C, Spitzer B, Stutzke C, Lavallee VP, Hebert J, Krivtsov AV, Melnick A, Paietta EM, Tallman MS, Letai A, Sauvageau G, Pouliot G, Levine R, Marto JA, Armstrong SA, Kentsis A Cancer Discov. 2018 Apr;8(4):478-497. doi: 10.1158/2159-8290.CD-17-1271. Epub 2018 Feb 5.
PubMed Journal

Articles Citing MSCV-IRES-Tomato MEF2C S222A

Articles
Nucleolar localization of RAG1 modulates V(D)J recombination activity. Brecht RM, Liu CC, Beilinson HA, Khitun A, Slavoff SA, Schatz DG. Proc Natl Acad Sci U S A. 2020 Feb 25;117(8):4300-4309. doi: 10.1073/pnas.1920021117. Epub 2020 Feb 11. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.